{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:40:29Z","timestamp":1786653629677,"version":"build-2736575974"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      Bacille Calmette\u2013Guerin (BCG) vaccine is the only vaccine that is used against\n                      <jats:italic toggle=\"yes\">Mycobacterium tuberculosis<\/jats:italic>\n                      , but its efficacy is limited in mycobacterium-endemic regions. One of the major antigens present on the cell envelope of the vaccine that suppresses the immune system is mannosylated lipoarabinomannan (ManLAM).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>In this study, we immunized 4-week-old mice with sonicated BCG vaccine injected intraperitoneally two times at an interval of 2 weeks and with ManLAM antigen injected intravenously and then extracted the spleen cells of the immunized mice. They were fused with SP2\/0 myeloma cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Five cell line clones producing antibody against ManLAM antigens were prepared and each clone was tested for immunoreactivity against sonicated BCG and purified ManLAM by enzyme-linked immunosorbent assay (ELISA) and immunoblotting. The clones designated H13F33E11 and H23D91G4 reacted strongly with ManLAM. Immunoblotting using monoclonal antibodies (MAbs) H13F33E11 and H23D91G4 showed that these MAbs bind to ManLAM with a molecular weight of 35 kDa.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>In this study, we produced a monoclonal antibody of immunoglobulin G3 (IgG3) subclass. This MAb can be used for purification of ManLAM in culture media and detection of the antigen in patient's urine and for increasing the efficacy of BCG vaccine.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/2277-9175.175901","type":"journal-article","created":{"date-parts":[[2016,2,8]],"date-time":"2016-02-08T01:49:15Z","timestamp":1454896155000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Preparation of monoclonal antibodies against mannosylated lipoarabinomannan (ManLAM), a surface antigen of BCG vaccine produced in Iran"],"prefix":"10.4103","volume":"5","author":[{"given":"Mohammad","family":"Taghikhani","sequence":"first","affiliation":[{"name":"Department of Clinical Biochemistry, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasul","family":"Moukhah","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, School of Medicine, The University of Tarbiat Modares, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2016,2,8]]},"reference":[{"key":"R1-20251008","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jama.282.7.677","article-title":"Consensus statement. Global burden of tuberculosis: Estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project","volume":"282","author":"Dye","year":"1999","journal-title":"JAMA"},{"key":"R2-20251008","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"key":"R3-20251008","first-page":"1","article-title":"The history of modern biotechnology in Iran: A medical review","volume":"3","author":"Fard","year":"2013","journal-title":"J Biotechnol Biomater"},{"key":"R4-20251008","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1128\/CMR.11.3.514","article-title":"Serum therapy for tuberculosis revisited: Reappraisal of the role of antibody-mediated immunity against Mycobacterium tuberculosis","volume":"11","author":"Glatman-Freedman","year":"1998","journal-title":"Clin Microbiol Rev"},{"key":"R5-20251008","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.micinf.2005.12.004","article-title":"Passive serum therapy with polyclonal antibodies against Mycobacterium tuberculosis protects against post-chemotherapy relapse of tuberculosis infection in SCID mice","volume":"8","author":"Guirado","year":"2006","journal-title":"Microbes Infect"},{"key":"R6-20251008","doi-asserted-by":"crossref","first-page":"6711","DOI":"10.1128\/IAI.73.10.6711-6720.2005","article-title":"Enhancement of innate and cell-mediated immunity by antimycobacterial antibodies","volume":"73","author":"de Valli\u00e8re","year":"2005","journal-title":"Infect Immun"},{"key":"R7-20251008","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1099\/00221287-139-11-2649","article-title":"Structure and antigenicity of lipoarabinomannan from Mycobacterium bovis BCG","volume":"139","author":"Prinzis","year":"1993","journal-title":"J Gen Microbiol"},{"key":"R8-20251008","doi-asserted-by":"crossref","first-page":"12401","DOI":"10.1016\/S0021-9258(18)31404-2","article-title":"Structural features of lipoarabinomannan from Mycobacterium bovis BCG. Determination of molecular mass by laser desorption mass spectrometry","volume":"268","author":"Venisse","year":"1993","journal-title":"J Biol Chem"},{"key":"R9-20251008","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/35084083","article-title":"The heparin-binding hemagglutinin of M. tuberculosis is required for extrapulmonary dissemination","volume":"412","author":"Pethe","year":"2001","journal-title":"Nature"},{"key":"R10-20251008","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1093\/glycob\/cws078","article-title":"Isolation of a distinct Mycobacterium tuberculosis mannose-capped lipoarabinomannan isoform responsible for recognition by CD1b-restricted T cells","volume":"22","author":"Torrelles","year":"2012","journal-title":"Glycobiology"},{"key":"R11-20251008","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2249.2004.02593.x","article-title":"A mycobacterial lipoarabinomannan specific monoclonal antibody and its F(ab\u2019) fragment prolong survival of mice infected with Mycobacterium tuberculosis","volume":"138","author":"Hamasur","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"R12-20251008","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/eji.1830060713","article-title":"Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion","volume":"6","author":"K\u00f6hler","year":"1976","journal-title":"Eur J Immunol"},{"key":"R13-20251008","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"R14-20251008","doi-asserted-by":"crossref","first-page":"7477","DOI":"10.4049\/jimmunol.166.12.7477","article-title":"Mannosylated lipoarabinomannans inhibit IL-12 production by human dendritic cells: Evidence for a negative signal delivered through the mannose receptor","volume":"166","author":"Nigou","year":"2001","journal-title":"J Immunol"},{"key":"R15-20251008","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1046\/j.1365-3156.1997.d01-151.x","article-title":"Evalutoin of a commercial immunodiagnostic kit incorporating lipoarabinomannan in the serodiagnosis of pulmonary tuberculosis in Ghana","volume":"2","author":"Lawn","year":"1997","journal-title":"Trop Med Int Health"},{"key":"R16-20251008","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.4049\/jimmunol.150.7.2920","article-title":"Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors","volume":"150","author":"Schlesinger","year":"1993","journal-title":"J Immunol"},{"key":"R17-20251008","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1574-695X.1999.tb01259.x","article-title":"A new rapid and simple method for large-scale purification of mycobacterial lipoarabinomannan","volume":"24","author":"Hamasur","year":"1999","journal-title":"FEMS Immunol Med Microbiol"},{"key":"R18-20251008","doi-asserted-by":"crossref","first-page":"15012","DOI":"10.1074\/jbc.270.25.15012","article-title":"Structural analysis of the mannan region of lipoarabinomannan from Mycobacterium bovis BCG. Heterogeneity in phosphorylation state","volume":"270","author":"Venisse","year":"1995","journal-title":"J Biol Chem"},{"key":"R19-20251008","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0161-5890(78)90070-6","article-title":"Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose","volume":"15","author":"Ey","year":"1978","journal-title":"Immunochemistry"},{"key":"R20-20251008","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2958.2004.04183.x","article-title":"Mycobacterial lipoarabinomannan and related lipoglycans: From biogenesis to modulation of the immune response","volume":"53","author":"Briken","year":"2004","journal-title":"Mol Microbiol"},{"key":"R21-20251008","first-page":"461","article-title":"Production and characterization of a murine monoclonal antibody recognizating a shared mycobacterial polysaccharide","volume":"52","author":"Miller","year":"1984","journal-title":"Int J Lepr Other Mycobact Dis"}],"container-title":["Advanced Biomedical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01679891-201605000-00015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:40:11Z","timestamp":1786650011000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01679891-201605000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.4103\/2277-9175.175901","relation":{},"ISSN":["2277-9175"],"issn-type":[{"value":"2277-9175","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"2014-02-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-05-12","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}